Complex partial seizure — now termed focal seizure with impaired awareness per the 2017 ILAE classification — is defined by impaired level of consciousness during a focal seizure, most commonly arising from the temporal lobe. [1-2] Typical duration is 1–2 minutes, characterized by behavioral arrest, staring, unresponsiveness, and automatisms (lip smacking, chewing, repetitive hand movements), followed by a postictal period of confusion and amnesia. [1][3]
1. History
- Aura: Ask about preceding déjà vu, epigastric rising sensation, unusual tastes/smells, fear, or visual disturbances — these are highly localizing to temporal lobe origin [4-5]
- Ictal description (from witnesses): Behavioral arrest, staring, unresponsiveness, automatisms (oral or manual), duration, lateralized features (head turning, unilateral limb movements)
- Postictal state: Confusion duration (typically minutes), amnesia for the event, fatigue, headache, Todd's paralysis (transient focal weakness suggesting lateralization)
- Timing/triggers: Sleep deprivation, alcohol use/withdrawal, missed medications, menstrual cycle (catamenial epilepsy), illness/fever
- Frequency and progression: Prior staring spells, myoclonic jerks, or auras that may have been unrecognized seizures — many patients with a "first" convulsive seizure have had prior focal events [5]
- Important negatives: Loss of consciousness without warning (suggests generalized onset or syncope), eye closure during event (suggests psychogenic nonepileptic seizure), waxing/waning motor activity, pelvic thrusting [6]
2. Alarm Features
- Seizure duration >5 minutes (generalized tonic-clonic) or >10 minutes (focal with impaired awareness) → status epilepticus [6-7]
- Failure to return to baseline within 30–60 minutes post-seizure [5]
- New focal neurologic deficits persisting beyond the postictal period
- Fever, nuchal rigidity, or immunocompromise → concern for CNS infection [8]
- Acute head trauma or anticoagulant use → emergent CT for intracranial hemorrhage
- First seizure in a patient with known malignancy → brain metastases
- Recurrent seizures without recovery (serial seizures/clustering)
- Pregnancy — eclampsia must be excluded
3. Medications
First-line treatment for focal epilepsy
- Lamotrigine — superior treatment retention in long-term pragmatic trials (SANAD II); slow titration required (start 25 mg daily, target 100–200 mg daily) to avoid rash [4][9]
- Levetiracetam — rapid titration possible (start 250 mg daily, target 1000–2000 mg daily in 2 doses); watch for irritability, anxiety, mood changes [4][10]
- Carbamazepine/oxcarbazepine — effective alternatives; enzyme-inducing, more drug interactions [6][10]
Acute seizure termination (if prolonged/status)
- Benzodiazepines first-line: lorazepam 4 mg IV or midazolam 10 mg IM [6]
- Second-line IV options: fosphenytoin, levetiracetam, valproic acid, lacosamide [6]
Medications that lower seizure threshold (caution/avoid)
- Tramadol, bupropion, meperidine, fluoroquinolones, carbapenems (imipenem), theophylline, high-dose cephalosporins
- Abrupt withdrawal of benzodiazepines, barbiturates, or alcohol
Contraindicated in focal epilepsy: Ethosuximide (absence-only efficacy) [11]
Special populations: Avoid valproate in women of childbearing potential due to teratogenicity (up to 10% major malformations, neurodevelopmental delay in up to 40%) [4][6]
4. Diet
- Alcohol is a well-established seizure trigger and should be minimized or avoided [4]
- Ketogenic diet may be considered in drug-resistant epilepsy (more commonly used in pediatrics, but evidence exists for adults)
- Caffeine in excess may lower seizure threshold
- Hydration: Avoid severe dehydration or overhydration (hyponatremia can provoke seizures)
- Grapefruit juice can interact with carbamazepine metabolism
5. Review of Systems
- Neurologic: Headache, vision changes, weakness, numbness, speech difficulty, memory problems
- Psychiatric: Depression, anxiety, psychosis (common comorbidities in temporal lobe epilepsy; also side effects of levetiracetam)
- Infectious: Fever, neck stiffness, recent illness
- Endocrine/metabolic: Symptoms of hypoglycemia, thyroid disease
- Cardiac: Palpitations, presyncope (to distinguish from cardiac syncope with convulsive movements)
- Substance use: Alcohol, recreational drugs (cocaine, methamphetamine), medication compliance
6. Collateral History and Family History
- Witness account is critical — patients are typically amnestic to the event; evaluate patient and witness accounts separately to enhance diagnostic accuracy [1][5]
- Home video recordings of events are invaluable for diagnosis [11]
- Family history: Rarely positive for epilepsy in focal epilepsy (unlike generalized epilepsy syndromes), but may be positive in familial focal epilepsy syndromes (e.g., autosomal dominant nocturnal frontal lobe epilepsy) [6]
- Social context: Driving status, occupation, living situation (safety if living alone), childcare responsibilities
7. Risk Factors
- Structural brain lesions: Prior stroke, TBI (especially with loss of consciousness), brain tumors, cortical malformations, hippocampal sclerosis [5-6]
- CNS infections: Meningitis, encephalitis (especially HSV), neurocysticercosis, brain abscess
- Perinatal injury: Birth complications, prolonged febrile seizures in childhood
- Neurosurgical history: Prior craniotomy
- Neurodegenerative disease: Alzheimer's disease (increased seizure risk)
- Substance use: Alcohol withdrawal, cocaine, methamphetamine [4]
- Sleep deprivation [4]
- Age: Bimodal distribution — higher incidence in young and elderly populations [9]
8. Differential Diagnosis
- Syncope (especially convulsive syncope) — fading vision, brief duration (<30 sec), rapid recovery; can have irregular jerks mimicking seizure [4][6]
- Psychogenic nonepileptic seizures (PNES) — eye closure during event, waxing/waning movements, prolonged duration (>3 min), slow postictal recovery; may coexist with epilepsy [6]
- Transient ischemic attack (TIA) — negative symptoms (weakness, numbness) rather than positive symptoms; typically no impaired awareness
- Absence seizures — brief (5–30 sec), no postictal confusion, generalized 3 Hz spike-wave on EEG; distinguish from focal impaired awareness seizures based on epilepsy type [2]
- Transient global amnesia — isolated amnesia without automatisms or impaired responsiveness
- Complex migraine with aura — longer duration, headache association
- Sleep disorders (parasomnias, narcolepsy with cataplexy)
- Hypoglycemia — check glucose in all patients [12]
9. Past Medical History
- Prior seizures (including unrecognized auras or staring spells)
- Head trauma, stroke, CNS infections, brain surgery
- Febrile seizures in childhood (especially prolonged → risk for mesial temporal sclerosis)
- Neurocutaneous syndromes: tuberous sclerosis, neurofibromatosis, Sturge-Weber [5]
- Psychiatric comorbidities (depression, anxiety — common in temporal lobe epilepsy)
- Current antiseizure medication use and compliance
- Substance use history
10. Physical Exam
- Vital signs: Fever (infection), hypertension (posterior reversible encephalopathy syndrome, eclampsia), hypoglycemia
- Neurologic exam (after postictal period resolves):
- Mental status and orientation
- Cranial nerves — visual field deficits, papilledema
- Motor — lateralizing weakness (Todd's paralysis suggests focal onset), pronator drift
- Sensory — asymmetry
- Reflexes — asymmetry, Babinski sign
- Language — aphasia (left temporal focus)
- Skin: Neurocutaneous stigmata (ash-leaf spots, café-au-lait spots, port-wine stain) [5]
- Tongue: Lateral tongue bite (highly suggestive of epileptic seizure vs. tip-of-tongue bite in PNES) [8]
- Signs of trauma: Head lacerations, shoulder dislocations, vertebral compression fractures [5]
11. Lab Studies
- Point-of-care glucose — immediate, in all patients
- Basic metabolic panel — sodium (hyponatremia is a common provoking factor), calcium, glucose, renal function [8]
- CBC — if infection suspected
- Hepatic function panel — baseline before starting antiseizure medications; also identifies hepatic encephalopathy [13]
- Toxicology screen — if substance use suspected (not routine for all first seizures) [8]
- Serum prolactin — may be elevated 10–20 minutes post-seizure (sensitivity ~78%), but limited specificity; a normal level may help support PNES diagnosis [8]
- Antiseizure medication levels — in known epilepsy patients to assess compliance
- Pregnancy test — in women of childbearing age
- Lumbar puncture — if fever, nuchal rigidity, immunocompromise, or persistent altered mental status after normal imaging [8]
12. Imaging
First-line
- CT head without contrast[5][8]
Gold standard
- MRI brain with epilepsy-specific protocol — includes thin 1–3 mm slices and coronal FLAIR sequences; superior sensitivity for hippocampal sclerosis, focal cortical dysplasia, low-grade gliomas, cavernous malformations, and periventricular heterotopias [5][14]
- All patients with a suspected focal-onset seizure should undergo detailed MRI [4]
- Up to 30% of patients with a first seizure have abnormalities on brain imaging; detection rate increases to ~30% with MRI vs. ~10% with CT alone [5][8]
When imaging is unnecessary
The following figure from JAMA illustrates a systematic approach to evaluating patients with new-onset seizure, including imaging and workup decision points:
13. Special Tests
- EEG — should be performed in all patients with suspected seizures; ideally within 24 hours of the event for highest yield [6][8]
- Interictal findings: focal epileptiform discharges (spikes/sharp waves) over the temporal region
- Ictal findings: rhythmic 5–7 Hz theta discharges over the temporal lobe [1]
- A normal EEG does not exclude epilepsy (~50% of first EEGs are normal in epilepsy patients) [6][13]
- Sleep-deprived EEG or prolonged ambulatory EEG increases sensitivity to ~85% [15]
- Continuous EEG monitoring — indicated if failure to return to baseline, waxing/waning consciousness, or concern for nonconvulsive status epilepticus; yield >90% with 24–36 hours of monitoring [5]
- Video-EEG monitoring — gold standard for distinguishing epileptic seizures from PNES [6]
- Serum prolactin (drawn 10–20 min post-event) — adjunctive, not diagnostic [8]
14. ECG
- 12-lead ECG is essential in all patients with a first seizure or unexplained blackout [4][11]
- Rule out cardiac syncope mimicking seizure: prolonged QT, Brugada pattern, Wolff-Parkinson-White, heart block, arrhythmias
- Cardiac syncope can produce convulsive movements (convulsive syncope) that mimic seizure
- Some antiseizure medications affect cardiac conduction (e.g., lacosamide prolongs PR interval; carbamazepine can cause AV block)
15. Assessment
Typical presentation: An aura (epigastric rising, déjà vu, fear) followed by behavioral arrest, staring, oral/manual automatisms, unresponsiveness lasting 1–2 minutes, then postictal confusion and amnesia for the event. Most commonly arises from the temporal lobe. [1][3]
Atypical presentations
- Frontal lobe origin: Shorter duration (15–30 sec), hypermotor activity (bicycling, thrashing), often nocturnal, minimal postictal confusion [3]
- Subtle presentations: Isolated staring or confusion without obvious automatisms — may be mistaken for psychiatric illness or inattention
- Focal to bilateral tonic-clonic: Any focal seizure with impaired awareness can secondarily generalize [3]
Severity stratification
- Isolated, self-limited event with return to baseline → outpatient workup appropriate
- Prolonged (>10 min), recurrent, or failure to return to baseline → status epilepticus protocol [6]
Complications: Injury from falls, aspiration, SUDEP (sudden unexpected death in epilepsy — higher risk with uncontrolled focal to bilateral tonic-clonic seizures), driving accidents, psychosocial impact [16]
16. Treatment Plan
Acute management (active seizure)
- Protect from injury, position on side, do not restrain
- If seizure >5 min: benzodiazepine — midazolam 10 mg IM, lorazepam 4 mg IV, or diazepam 10 mg rectal [6]
- Assess and correct reversible causes: glucose, electrolytes, temperature
Initiation of antiseizure medication
- Not mandatory after a single unprovoked seizure if low recurrence risk; shared decision-making is appropriate [8][11]
- Treatment recommended if: abnormal EEG, structural brain lesion on MRI, nocturnal seizure, prior brain insult, or patient preference to minimize recurrence risk [8]
- First-line for focal epilepsy: lamotrigine or levetiracetam [4][9-10]
- Levetiracetam preferred when rapid seizure control is needed (can be titrated quickly)
- Lamotrigine preferred for long-term tolerability (requires slow titration over 4–6 weeks)
Refractory focal epilepsy
- Add-on or switch to carbamazepine, oxcarbazepine, lacosamide, zonisamide, brivaracetam, or perampanel [11]
- Referral to epilepsy center for surgical evaluation if drug-resistant (failure of 2 appropriate antiseizure medications)
17. Disposition
Admit if
- Failure to return to baseline neurologic function within 30–60 minutes [5]
- Status epilepticus or recurrent seizures
- New focal neurologic deficits
- Acute structural lesion on imaging (stroke, hemorrhage, tumor)
- Suspected CNS infection
- Waxing/waning level of consciousness (concern for nonconvulsive status epilepticus)
- Inability to obtain timely outpatient EEG/MRI [5]
Discharge if
- Return to baseline neurologic function
- Normal or non-acute CT (if obtained)
- No acute provoking factor requiring inpatient management
- Safe home environment with a responsible adult
- Reliable outpatient follow-up arranged
Observation
Specialist consultation triggers
- All patients with a first unprovoked seizure should be referred to neurology [11]
- Epilepsy center referral for drug-resistant seizures (failure of ≥2 medications), surgical candidacy evaluation, or diagnostic uncertainty [15]
18. Follow Up / Return Precautions
Follow-up timing
- Neurology follow-up within 1–2 weeks of a first seizure
- EEG ideally within 24–48 hours (highest yield), but can be safely delayed if treatment does not depend on the result [5][8]
- Epilepsy-protocol MRI as outpatient if not obtained emergently [5]
Return precautions — advise return for
- Another seizure or seizure lasting >5 minutes
- Persistent confusion, weakness, speech difficulty, or vision changes
- Fever, severe headache, or neck stiffness
- Medication side effects (rash with lamotrigine — especially in first 8 weeks; mood changes with levetiracetam)
Patient counseling
- Driving restrictions — varies by jurisdiction; typically seizure-free interval of 3–12 months required [4]
- Avoid sleep deprivation, excessive alcohol, and known personal triggers [4]
- Avoid solitary swimming, heights, and operating heavy machinery until seizure control is established
- Discuss SUDEP risk in appropriate context (higher with uncontrolled generalized tonic-clonic seizures)
- Women of childbearing age: discuss contraception interactions (enzyme-inducing antiseizure medications reduce hormonal contraceptive efficacy) and preconception planning [4]
Expected recovery
- Approximately 70% of patients with epilepsy achieve seizure remission with appropriate antiseizure medication [9]
- About one-third of adults experience a second seizure within one year of a first unprovoked seizure; nearly half within two years [8]
- Recurrence risk >60% if structural lesion identified on MRI [5]
References
1. Impaired Consciousness in Epilepsy. — Blumenfeld H. The Lancet. Neurology. 2012.
2. Improving Epilepsy Diagnosis Across the Lifespan: Approaches and Innovations. — Pellinen J, Foster EC, Wilmshurst JM, Zuberi SM, French J. The Lancet. Neurology. 2024.
3. Prognosis of Adults and Children Following a First Unprovoked Seizure. — Neligan A, Adan G, Nevitt SJ, et al. The Cochrane Database of Systematic Reviews. 2023.
4. Initial Management of Seizure in Adults. — Smith PEM. The New England Journal of Medicine. 2021.
5. New-Onset Seizure in Adults and Adolescents: A Review. — Gavvala JR, Schuele SU. The Journal of the American Medical Association. 2016.
6. Adult Epilepsy. — Asadi-Pooya AA, Brigo F, Lattanzi S, Blumcke I. Lancet. 2023.
7. 2024 American Heart Association and American Red Cross Guidelines for First Aid. — Hewett Brumberg EK, Douma MJ, Alibertis K, et al. Circulation. 2024.
8. Evaluation After a First Seizure in Adults. — Rowland K, Lambert CE. American Family Physician. 2022.
9. The SANAD II Study of the Effectiveness and Cost-Effectiveness of Levetiracetam, Zonisamide, or Lamotrigine for Newly Diagnosed Focal Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial. — Marson A, Burnside G, Appleton R, et al. Lancet. 2021.
10. Antiepileptic Drug Monotherapy for Epilepsy: A Network Meta-Analysis of Individual Participant Data. — Nevitt SJ, Sudell M, Cividini S, Marson AG, Tudur Smith C. The Cochrane Database of Systematic Reviews. 2022.
11. Epilepsy in Adults. — Thijs RD, Surges R, O'Brien TJ, Sander JW. Lancet. 2019.
12. An Emergency Medicine-Focused Review of Seizure Mimics. — Webb J, Long B, Koyfman A. The Journal of Emergency Medicine. 2017.
13. Initial Management of Epilepsy. — French JA, Pedley TA. The New England Journal of Medicine. 2008.
14. ESR Essentials: Image Evaluation of Patients With Seizures and Epilepsy-Practice Recommendations by the European Society of Neuroradiology. — Bargalló N, Vitali P, Álvarez-Linera J, et al. European Radiology. 2025.
15. Antiseizure Medications for Adults With Epilepsy: A Review. — Kanner AM, Bicchi MM. The Journal of the American Medical Association. 2022.
16. Consciousness as a Useful Concept in Epilepsy Classification. — Blumenfeld H, Meador KJ. Epilepsia. 2014.